Vinay Shah - Jun 20, 2023 Form 4/A - Amendment Insider Report for Virpax Pharmaceuticals, Inc. (VRPX)

Role
Chief Financial Officer
Signature
/s/ Vinay Shah
Stock symbol
VRPX
Transactions as of
Jun 20, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
8/16/2023, 05:00 PM
Date Of Original Report
Jun 21, 2023
Previous filing
Jan 25, 2022
Next filing
Jan 31, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRPX Stock Option (right to buy) Award $0 +100K $0.00 100K Jun 20, 2023 Common Stock 100K $0.99 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option will vest after 12 months of continuous service, and the remaining 75% of the shares subject to the Option will vest in equal monthly installments over the next 24 months of continuous service